Neuroleptic Malignant Syndrome Associated With Lurasidone: A Case Report

J Clin Psychopharmacol. 2023 Nov-Dec;43(6):548-549. doi: 10.1097/JCP.0000000000001781. Epub 2023 Oct 23.

Authors

Samuel Pàmpols-Pérez, Arnau Gisbert-Solà, Belen Resa-Pérez, Andrea Jiménez-Mayoral, Irene Forcada-Pach, Vicent Llorca-Bofi

PMID: 37930214
DOI: 10.1097/JCP.0000000000001781

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antipsychotic Agents* / adverse effects
Humans
Lurasidone Hydrochloride / adverse effects
Neuroleptic Malignant Syndrome* / diagnosis
Neuroleptic Malignant Syndrome* / etiology

Substances

Lurasidone Hydrochloride
Antipsychotic Agents